Acquired by Agilent Technologies.
Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.
Acquired by Agilent Technologies.
AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products
Axithra is developing new technology for accurate drug concentrations in blood.
Spica Therapeutics is pioneering Macrophage-Subset targeted therapies
